APA (7th ed.) Citation

JA, I., A, v. N. S., JW, J., B, R., EM, S., CK, M., . . . AM, v. d. H. (2025). Efficacy of a novel PCSK9 inhibitory peptide alone and with evinacumab in a mouse model of atherosclerosis. Journal of lipid research, 66(3), 100753. https://doi.org/10.1016/j.jlr.2025.100753

Chicago Style (17th ed.) Citation

JA, Inia, van Nieuwkoop-van Straalen A, Jukema JW, Rolin B, Staarup EM, Mogensen CK, Princen HMG, and van den Hoek AM. "Efficacy of a Novel PCSK9 Inhibitory Peptide Alone and with Evinacumab in a Mouse Model of Atherosclerosis." Journal of Lipid Research 66, no. 3 (2025): 100753. https://doi.org/10.1016/j.jlr.2025.100753.

MLA (9th ed.) Citation

JA, Inia, et al. "Efficacy of a Novel PCSK9 Inhibitory Peptide Alone and with Evinacumab in a Mouse Model of Atherosclerosis." Journal of Lipid Research, vol. 66, no. 3, 2025, p. 100753, https://doi.org/10.1016/j.jlr.2025.100753.